The global Nucleic Acid Amplification Testing market size is expected to be worth around US$ 14.4 billion by 2030, according to a new report by Vision Research Reports.
The global Nucleic Acid Amplification Testing market size was valued at US$ 11.78 billion in 2020 and is anticipated to grow at a CAGR of 20.45 % during forecast period 2022 to 2030.
Nucleic acid amplification testing is gaining preference over traditional diagnostic techniques because of its high efficiency and accuracy. In addition, the potential application of these tests in various life-threatening diseases, including several types of cancer, is attracting a large amount of investment for the purpose of R&D. Increasing number of ongoing studies are expected to ensure higher growth rate in the later part of the forecast period.
These tests are currently being used extensively for screening and diagnosis of a wide range of infectious diseases. Along with known infectious diseases, management of epidemics of new diseases has caused a sudden surge in the demand for advanced diagnostic tests. NAAT is currently the most advanced and efficient diagnostic method, which extensively uses technology that helps in reducing procedural time and consumption of reagents.
The PCR tests segment recorded the largest market share of 66.68% in 2021. The technology enables rapid and sensitive detection of a broad range of target nucleic acid molecules and can be used for the detection of specific pathogens that may be difficult to culture in vitro. In addition, widespread penetration of PCR technology has enabled applications of the technique for the detection, quantification, and genotyping of a variety of bacteria and viruses from several types of clinical specimens, including plasma, serum, semen, cerebrospinal fluid, and others. As a result, the PCR tests segment is expected to witness significant growth during the forecast period.
The Isothermal Nucleic Acid Amplification Technology (INAAT) tests segment is projected to expand at a rapid CAGR during the forecast period due to the introduction of novel technologies, such as loop-mediated isothermal amplification (LAMP), strand displacement amplification, and recombinase polymerase amplification, among others, that are broadening the scope of the applications for nucleic acid-based test products.
For instance, in June 2022, a research study published in the Analyst Journal demonstrated a new smartphone-integrated technology that can perform rapid Zika virus testing in a single blood drop with the help of the LAMP technology. Such advancements are anticipated to drive the segment and positively affect market growth.
The infectious disease segment held the largest market share of 46.16% in 2021. This can be attributed to the widespread prevalence and rising incidence rate of infectious diseases such as influenza, sexually transmitted infections, and others. The COVID-19 testing sub-segment held the largest share in 2021 within the infectious disease testing segment due to the global presence of the pandemic and the launch of several new PCR tests.
For instance, in October 2020, Euro fins Central Laboratory launched its Empower DX SARS CoV 2 RT PCR test with the option for at-home sampling. Such product launches are expected to increase the market penetration of PCR tests and drive segment growth.
Oncology testing segment is projected to expand at the fastest CAGR during the forecast period due to the rise in R&D interests for the development of novel cancer diagnostic alternatives and rapid progress in cancer research. For instance, in March 2022, researchers from Queen Mary University of London announced the development of the first PCR test for the detection of oral cancer. Such advancements are likely to fuel growth prospects for the nucleic acid amplification testing of other ontological conditions in the near future.
The central and reference laboratories segment dominated the market in 2021 due to its extensive testing portfolio and coverage across multiple healthcare settings. In addition, supportive government initiatives are aiding in the expansion of the testing capacities of such laboratories. For instance, in June 2022, the Department of Health and Human Services (HHS) expanded the Monkeypox testing capacity to five laboratory companies, including Lab corp., Quest Diagnostics, Mayo Clinic Laboratories, Aegis Science, and Sonic Healthcare.
Hospitals segment is expected to grow at the fastest CAGR of 13.44% by 2030. The rise in healthcare expenditure globally and the increasing role of nucleic acid amplification techniques for disease surveillance and prevention of outbreaks are the factors leading to the growth of the segment. Similarly, growth in hospital testing capacities post-COVID-19 and availability of the high throughput testing capabilities can considerably boost the market prospects for nucleic acid amplification testing.
North America accounted for the largest market share 36.96% in 2021 due to the high extent of chronic disease prevalence and the presence of an established research and healthcare infrastructure. Similarly, demand for nucleic acid amplification tests is also driven by the increasing focus on point-of-care diagnostic methods and the high extent of disease prevention measures in the region.
Asia Pacific is expected to grow at the fastest rate during the forecast period due to the existence of a large population and rising focus on the healthcare systems. High incidence of emerging infectious diseases such as Japanese encephalitis, Hendra, and Nipah virus infections can strengthen the market prospects for nucleic acid amplification testing.
F. Hoffmann-La Roche Ltd; Becton, Dickinson and Company; Beckman Coulter, Inc.; Abbott Laboratories, Inc.; Illumina, Inc.; Siemens Healthineers; bioMérieux SA; Novartis AG; and Bio-Rad Laboratories, Inc.
Genetic and Mitochondrial Disorders
Target amplification systems
Probe amplification systems
The Nucleic Acid Amplification Testing market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Nucleic Acid Amplification Testing market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Nucleic Acid Amplification Testing market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nucleic Acid Amplification Testing market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Nucleic Acid Amplification Testing market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Nucleic Acid Amplification Testing capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Nucleic Acid Amplification Testing by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Nucleic Acid Amplification Testing market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Nucleic Acid Amplification Testing market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Nucleic Acid Amplification Testing market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Nucleic Acid Amplification Testing industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Nucleic Acid Amplification Testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Nucleic Acid Amplification Testing market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Nucleic Acid Amplification Testing market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Nucleic Acid Amplification Testing market. These factors have benefited the growth of the global market for Nucleic Acid Amplification Testing. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Nucleic Acid Amplification Testing. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Nucleic Acid Amplification Testing are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
To strategically profile the key players and comprehensively analyze their growth strategies.